ATE369149T1 - Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen - Google Patents

Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen

Info

Publication number
ATE369149T1
ATE369149T1 AT98920292T AT98920292T ATE369149T1 AT E369149 T1 ATE369149 T1 AT E369149T1 AT 98920292 T AT98920292 T AT 98920292T AT 98920292 T AT98920292 T AT 98920292T AT E369149 T1 ATE369149 T1 AT E369149T1
Authority
AT
Austria
Prior art keywords
diagnosis
chlamydia
preparations
treatment
several
Prior art date
Application number
AT98920292T
Other languages
English (en)
Inventor
William Mitchell
Charles Stratton
Original Assignee
Univ Vanderbilt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/025,176 external-priority patent/US6258532B1/en
Priority claimed from US09/025,174 external-priority patent/US6562582B2/en
Application filed by Univ Vanderbilt filed Critical Univ Vanderbilt
Application granted granted Critical
Publication of ATE369149T1 publication Critical patent/ATE369149T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT98920292T 1997-05-06 1998-05-06 Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen ATE369149T1 (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US4573997P 1997-05-06 1997-05-06
US4578797P 1997-05-06 1997-05-06
US4577997P 1997-05-06 1997-05-06
US4568997P 1997-05-06 1997-05-06
US4578097P 1997-05-06 1997-05-06
US4578497P 1997-05-06 1997-05-06
US91159397A 1997-08-14 1997-08-14
US2552198A 1998-02-18 1998-02-18
US09/025,176 US6258532B1 (en) 1997-08-14 1998-02-18 Methods for in vitro susceptibility testing of chlamydia
US09/025,174 US6562582B2 (en) 1996-08-14 1998-02-18 Chlamydia-free cell lines and animals

Publications (1)

Publication Number Publication Date
ATE369149T1 true ATE369149T1 (de) 2007-08-15

Family

ID=27580715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920292T ATE369149T1 (de) 1997-05-06 1998-05-06 Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen

Country Status (7)

Country Link
EP (1) EP0981372B1 (de)
AT (1) ATE369149T1 (de)
AU (1) AU746381B2 (de)
CA (1) CA2289228A1 (de)
DE (1) DE69838214T2 (de)
ES (1) ES2293678T3 (de)
WO (1) WO1998050074A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258532B1 (en) 1997-08-14 2001-07-10 Vanderbilt University Methods for in vitro susceptibility testing of chlamydia
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6579854B1 (en) * 1996-08-14 2003-06-17 Vanderbilt University Diagnosis and management of infection caused by chlamydia
US6664239B2 (en) 1997-05-06 2003-12-16 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
US6884784B1 (en) 1997-05-06 2005-04-26 Vanderbilt University Diagnosis and management of infection caused by chlamydia
US6756369B2 (en) 1997-05-06 2004-06-29 Vanderbilt University Diagnosis and management of infection caused by Chlamydia
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
AU3760400A (en) * 1999-03-19 2000-10-09 Vanderbilt University Methods and reagents for the diagnosis and treatment of multiple sclerosis
FR2791357B1 (fr) * 1999-03-26 2003-05-16 Didier Raoult Diagnostic de la maladie de whipple
US6191259B1 (en) * 1999-05-19 2001-02-20 Wisconsin Alumni Research Foundation Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
US6225443B1 (en) 1999-05-19 2001-05-01 Wisconsin Alumni Research Foundation Cytotoxic T lymphocyte epitopes of the major outer membrane protein of chlamydia trachomatis
RU2491932C2 (ru) * 2010-08-31 2013-09-10 Сергей Иванович Иванов Способ лечения клапанного аппарата сердца
CA3022947A1 (en) * 2016-05-04 2017-11-09 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE143414T1 (de) * 1985-01-14 1996-10-15 Chiron Corp Hauptprotein der aussenmembran von chlamydia
IL89894A0 (en) * 1988-04-13 1989-12-15 Pfizer Single dose intramuscular treatment of chlamydia trachomatis infections
AU2844792A (en) * 1991-12-11 1993-06-17 Becton Dickinson & Company Probes to chlamydia trachomatis
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection

Also Published As

Publication number Publication date
CA2289228A1 (en) 1998-11-12
WO1998050074A2 (en) 1998-11-12
ES2293678T3 (es) 2008-03-16
WO1998050074A3 (en) 1999-08-19
AU7289998A (en) 1998-11-27
DE69838214D1 (de) 2007-09-20
EP0981372B1 (de) 2007-08-08
EP0981372A2 (de) 2000-03-01
AU746381B2 (en) 2002-04-18
DE69838214T2 (de) 2008-05-08

Similar Documents

Publication Publication Date Title
ATE369149T1 (de) Zubereitungen von mehreren antichlamydialen mitteln zur diagnose und behandlung von durch chlamydia verursachten infektionen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
ATE364043T1 (de) Pyrazolo-pyridine für die behandlung von herpes- ansteckungen
ATE296612T1 (de) Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
ATE298741T1 (de) Polyaromatische verbindungen zur behandlung von herpes-infektionen
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
DE69729796D1 (de) Verwendung von synergistischen zusammensetzungen von il-12 und ifn-alpha für die behandlung von infektiösen krankheiten
TR200002965T2 (tr) Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı
EA200401522A1 (ru) Противотуберкулёзный препарат: композиции и способы
ATE226442T1 (de) Anti-chlamydia verfahren und mittel
ATE310088T1 (de) Behandlung und nachweis von staphylokokkeninfektionen
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
WO1998006435A3 (en) COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA)
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
DE69827633D1 (de) Oxidationszusammensetzung und verwendungen derselben für die behandlung von keratinischen fasern
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
TR200100637T2 (tr) Yeni doğal ürün türevleri
ES2132383T3 (es) Inhibidores de proteasa hiv.
ATE309803T1 (de) Sphingomyelinase inhibitoren als wirkstoffe mit antiapoptotischer und antiseptischer wirkung
BR9612196A (pt) Tiazolinas substituidas
DE69838980D1 (de) Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen
PT640098E (pt) Gene de coronavirus canino e suas utilizacoesc
RU94019991A (ru) Антибиотическая композиция
ATE137406T1 (de) Zubereitung für die topische behandlung von infektionen durch viren, bakterien und schimmel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties